The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass
-
Narrated by:
-
By:
About this listen
- Dr. Grant Tinsley joins the discussion as the body composition expert.
- Myostatin is a key regulator of muscle growth.
- Wendy Whippete the most jacked muscled up dog
- The concern of GLP-1 receptor agonists and muscle mass loss.
- Overview of Courage trial looking at semaglutide and trevogrumab and lean mass loss
- Upcoming Believe trial coming out (bimagrumab and semaglutide)
- Exercise remains crucial for muscle health and function.
- MRI data from SURPASS MRI provides new insights into muscle volume changes.
- The combination of medications may have varying effects on muscle mass.
- Caution is advised regarding the long-term effects of new drugs.
- Clinical benefits of medications often outweigh concerns about muscle loss.
- Future research will explore the synergy between exercise and medication.
Other docs who lift podcasts with Dr. Grant:
Tirzepatide muscle loss
Lean mass loss and GLP-1 meds
What listeners say about The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.